The PE Ratio as of November 2024 (TTM) for Nascent Biotech, Inc. (NBIO) is -5.83

According to Nascent Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.83. This represents a change of -64.59% compared to the average of -16.46 of the last 4 quarters.

Nascent Biotech, Inc. (NBIO) Historical PE Ratio (quarterly & annually)

How has NBIO PE Ratio performed in the past?

The mean historical PE Ratio of Nascent Biotech, Inc. over the last ten years is -7.24. The current -5.83 PE Ratio has changed 7.95% with respect to the historical average. Over the past ten years (40 quarters), NBIO's PE Ratio was at its highest in in the September 2022 quarter at 39.76. The PE Ratio was at its lowest in in the December 2023 quarter at -35.19.

Nascent Biotech, Inc. (NBIO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Nascent Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nascent Biotech, Inc. (NBIO) Average PE Ratio

How has NBIO PE Ratio performed in the past?

The current PE Ratio of Nascent Biotech, Inc. (NBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nascent Biotech, Inc. (NBIO) PE Ratio vs. Peers

How is NBIO’s PE Ratio compared to its peers?

Nascent Biotech, Inc.’s PE Ratio is greater than ProtoKinetix, Incorporated (-9.22), less than RespireRx Pharmaceuticals Inc. (-0.20), less than Silo Pharma, Inc. (-0.98), greater than VG Life Sciences Inc. (-20.33), less than Mymetics Corporation (0), less than Neutra Corp. (-0.00), less than Protagenic Therapeutics, Inc. (-1.64), less than Sino Biopharmaceutical Limited (0), less than ZIVO Bioscience, Inc. (-0.52), less than Cyteir Therapeutics, Inc. (16.30), less than Eledon Pharmaceuticals, Inc. (-5.20), greater than Innovation Pharmaceuticals Inc. (-9.12), less than Allena Pharmaceuticals, Inc. (17.15), less than YS Biopharma Co., Ltd. (0), less than null (-0.07), less than null (-0.07), less than null (-2.73),

Build a custom stock screener for Nascent Biotech, Inc. (NBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nascent Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nascent Biotech, Inc. (NBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nascent Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.